Concepedia

Boris Tchernychev

BT

Statistics

Publications

19

Citations

1.2K

H-Index

16

Active since

1995

Affiliations

Ironwood Pharmaceuticals (United States)(Current)

Weizmann Institute of Science

DecImmune Therapeutics (United States)

Tufts University

University of Tübingen

Boris Tchernychev is an author at Ironwood Pharmaceuticals (United States) specializing in pharmacology, life sciences, and cell signaling.

Publications per year

1995–2024

19

Publications

19

Targeted Gene Disruption Demonstrates That P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Required for P-Selectin–Mediated but Not E-Selectin–Mediated Neutrophil Rolling and Migration

Jing Yang, Takako Hirata, Kevin Croce et al. · The Journal of Experimental Medicine · 1999 · 317 citations · Full text

, , +17

Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site

Vishal Trivedi, Adrienne Boire, Boris Tchernychev et al. · Cell · 2009 · 244 citations · Full text

, , +14

Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells

Boris Tchernychev, Yong Ren, Jay M. Janz et al. · Proceedings of the National Academy of Sciences · 2010 · 115 citations · Full text

, , +17

Gastrointestinal pain: Unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation

Inmaculada Silos‐Santiago, Gerhard Hannig, Hélène Eutamène et al. · Pain · 2013 · 69 citations

, , +17

Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine

Md. Kaimul Ahsan, Boris Tchernychev, Marco M. Kessler et al. · Physiological Reports · 2017 · 50 citations · Full text

, , +17

1–5 of 19